International Biotechnology (LON:IBT) Shares Pass Above 200-Day Moving Average - Time to Sell?

Key Points

• International Biotechnology shares have surpassed their 200-day moving average, currently trading at GBX 826 ($11.07).
• The company has a market capitalization of £274.67 million and a price-to-earnings (PE) ratio of 17.20.
• International Biotechnology aims for long-term capital growth by investing in a diversified portfolio of biotechnology and life sciences companies with strong growth potential.

International Biotechnology (LON:IBT - )'s stock price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 639.25 ($8.57) and traded as high as GBX 832 ($11.15). International Biotechnology shares last traded at GBX 826 ($11.07), with a volume of 71,750 shares trading hands.

International Biotechnology Stock Up 0.7%

The company has a market cap of £274.67 million, a PE ratio of 17.20 and a beta of 0.21. The stock has a 50-day simple moving average of GBX 724.33 and a 200 day simple moving average of GBX 639.25.

About International Biotechnology

The Company's investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.